Evidence map›Paper›PMID 38829480›Full record

SynthesisMusculoskeletal surgery2024

Platelet lysate for the treatment of osteoarthritis: a systematic review of preclinical and clinical studies.

K Valtetsiotis, A Di Martino, M Brunello, C D'Agostino, R Poluzzi, R Ferri, P Mora, F Traina, C Faldini

Abstract readSystematic Review
In one paragraph

Synthesis in Musculoskeletal surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

K Valtetsiotis1st Orthopedic and Traumatology Department, IRCCS Istituto Ortopedico Rizzoli, Via Giulio Cesare Pupilli 1, 40136, Bologna, Italy.
A Di MartinoDepartment of Biomedical and Neuromotor Science-DIBINEM, University of Bologna, 40127, Bologna, Italy. albertocorrado.dimartino@ior.it.ORCID http://orcid.org/0000-0002-0716-4951
M BrunelloDepartment of Biomedical and Neuromotor Science-DIBINEM, University of Bologna, 40127, Bologna, Italy.
C D'AgostinoDepartment of Biomedical and Neuromotor Science-DIBINEM, University of Bologna, 40127, Bologna, Italy.
R PoluzziDepartment of Biomedical and Neuromotor Science-DIBINEM, University of Bologna, 40127, Bologna, Italy.
R FerriDepartment of Biomedical and Neuromotor Science-DIBINEM, University of Bologna, 40127, Bologna, Italy.
P MoraDepartment of Biomedical and Neuromotor Science-DIBINEM, University of Bologna, 40127, Bologna, Italy.
F TrainaDepartment of Biomedical and Neuromotor Science-DIBINEM, University of Bologna, 40127, Bologna, Italy.
C FaldiniDepartment of Biomedical and Neuromotor Science-DIBINEM, University of Bologna, 40127, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intra-articular injection-based therapy is often used aside conservative treatment and lifestyle modifications to manage knee osteoarthritis (KO) patients. Conventional injections contain steroids and hyaluronic acid, while more recently multipotential adult stem cell, platelet-rich plasma (PRP), and platelet lysate (PL) injections have been used to promote cartilage regeneration or repair. The aim of the current study is to analyse current evidence on PL injections for the treatment of KO and to determine if these are effective and how these perform compared to other injection regimens. The databases of Scopus, Embase, PubMed, Web of Science, and Cochrane Library were searched on 30 June 2023. Risk of bias was assessed using the SYRCLE tool for animal studies and Cochrane RoB 2 as well as ROBINS-I tool for human studies. Studies were included if these were in English, any year, and regarded animals with osteoarthritis (OA) or human adult patients with OA. In vitro trials and non-adult human studies were excluded. Results on OA symptom stage and severity, and pain were recorded. The research retrieved three human studies (n = 48, n = 25, n = 58) and four animal studies: one rabbit, two studies, and one rat study. PL was found to decrease KO symptoms at follow-up ≤ 1 year with respect to baseline levels and when compared to hyaluronic acid or platelet-rich plasma. Symptoms returned 6 months-1 year after the final administration, with studies showing peak efficacy at approximately 6 months. Animal studies showed clinical improvements, reduction of lameness, and partial effect on the cartilage regeneration of the seven studies, two had a high risk of bias, four were associated to some concerns, and one had low risk. A major source of bias in these studies was the use of questionnaires and scoring that could be subject to interpretation. Overall, PL was well-tolerated and showed efficacy comparable to PRP; when pain control was assessed, it showed similar efficacy compared to hyaluronic acid. These findings may support its use in clinical trials to confirm these initial findings; future research should also focus on the comparison with other non-surgical treatments, on a more detail of the potential regenerative properties, and to optimise the treatment schedule.

Indexed as

Blood PlateletsOsteoarthritis, KneeAnimalsDisease Models, AnimalHumansInjections, Intra-ArticularPlatelet-Rich PlasmaRabbitsRatsTreatment OutcomeInjectionKneeOsteoarthritisPlatelet lysate

Identifiers

PMID38829480
PMCPMC11371856

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.